comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists in Diseases: Mechanisms, Clinical Evidence, Emerging Therapies GLP-1 receptor agonists and next-generation

Most notable is a study of cardiovascular outcomes among 2,287 patients with type 2 diabetes and obesity who underwent bariatric surgery at Cleveland Clinic and 11,435 matched controls ( JAMA

In many case reports, the use of these drugs, mainly exenatide, has been associated with acute kidney injury, in which hemodynamic factors are predominantly implicated

The idea that one can accurately identify delayed gastric emptying without performing imaging (such as bedside gastric ultrasound) is not rooted in reality

The emerging role of glucagon-like peptide-1 receptor agonists for the management of NAFLD

doi: 10.1016/j.bcp.2017.02.012 83 BaldassanoSGasbjergLSKizilkayaHSRosenkildeMMHolstJJHartmannBet al

Clinical efficacy studies of various unimolecular dual and triple agonists targeting the GLP- 1 receptor, GIP receptor, and glucagon receptor have shown promising results when used alone or in conjunction with approved hypoglycemic medications